Composition for improving premature ovarian failure, preparation method therefor and application of composition

A premature ovarian failure and composition technology, which is applied in the field of improving premature ovarian failure composition and its preparation, can solve the problems of immune risk, failure to completely restore ovarian function, and influence on cell biological activity and function, so as to ensure biological activity and function Play, avoid the loss of cell activity, and improve the effect of ovarian microenvironment

Pending Publication Date: 2021-08-13
陕西中鸿科瑞再生医学研究院有限公司
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Drug treatment mainly consists of taking Chinese and Western medicines. Chinese medicines are taken for a long time, the effect is not obvious, and it is easy to cause liver and kidney toxicity. Western medicines are mainly hormone drugs, but taking hormones for a long time has side effects and cannot completely restore ovarian function; surgical treatment mainly For malnutrition-induced premature ovarian failure caused by vascular factors, intra-ovarian vascular bypass surgery is required, with high risk and strong pain for patients; stem cell and stem cell derivative therapy is currently an emerging therapy, including mesenchymal stem cell suspension injection therapy and Stem Cell Exosome Therapy
Although both mesenchymal stem cell suspension therapy and exosome therapy have made some progress, the cells are prone to absorption and diffusion after injection of single cell suspension, and cannot achieve uniform distribution, resulting in low repair efficiency, while exosomes with tissue The microenvironment changes, so the range of treatment is narrow, suitable for primary premature ovarian failure
The tissue engineering method is to combine seed cells and exogenous scaffold materials to form a biologically active tissue substitute, but the seed cells must be collected after trypsin digestion, which destroys the original extracellular matrix and intercellular junction proteins, affecting The biological activity and function of cells, and so far, there is no fully qualified scaffold material, and most of the collagen scaffold materials currently used are of animal origin, and there are immune risks
[0003] In summary, the problem in the prior art is that there is a lack of a drug for the treatment of premature ovarian failure with few side effects, a wide range of treatment and high safety.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition for improving premature ovarian failure, preparation method therefor and application of composition
  • Composition for improving premature ovarian failure, preparation method therefor and application of composition
  • Composition for improving premature ovarian failure, preparation method therefor and application of composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] The present invention provides a composition for improving premature ovarian failure, including human endometrial stem cell sheet and mesenchymal stem cell exosomes, the composition is prepared according to the following steps:

[0043] S1, Preparation of Endometrial Stem Cell Sheets

[0044] Culture of human endometrial stem cells: Human endometrial stem cells of the 5th passage (cultivation started from passage 0) were inoculated in a six-well plate, added with endometrial stem cell medium for culture, and the original medium was discarded after 12 hours of culture , change the cell membrane induction medium to continue culturing, and change the cell membrane induction medium every 1 d. After the culture, a translucent cell membrane appears in the culture well. The edge of the cell membrane is rolled up and can be picked up with tweezers. The cell membrane has certain toughness and is not easy to be damaged, which proves that the membrane is mature. The human endomet...

Embodiment 2

[0060] The present invention provides a composition for improving premature ovarian failure, including human endometrial stem cell sheet and mesenchymal stem cell exosomes, the composition is prepared according to the following steps:

[0061] S1, Preparation of Endometrial Stem Cell Sheets

[0062] Culture of human endometrial stem cells: Human endometrial stem cells of the 10th passage (cultivation started from passage 0) were inoculated in a six-well plate, added with endometrial stem cell medium for culture, and the original medium was discarded after 15 hours of culture , change the cell membrane induction medium to continue culturing, and change the cell membrane induction medium every 2 days. After the culture, a translucent cell membrane appears in the culture well. The edge of the cell membrane is rolled up and can be picked up with tweezers. The cell membrane has certain toughness and is not easy to be damaged, which proves that the membrane is mature.

[0063] The ...

Embodiment 3

[0078] The present invention provides a composition for improving premature ovarian failure, including human endometrial stem cell sheet and mesenchymal stem cell exosomes, the composition is prepared according to the following steps:

[0079] S1, Preparation of Endometrial Stem Cell Sheets

[0080] Culture of human endometrial stem cells: Human endometrial stem cells of the third generation (cultivation started from passage 0) were inoculated in a six-well plate, added with endometrial stem cell medium for culture, and the original medium was discarded after 12 hours of culture , change the cell membrane induction medium to continue culturing, and change the cell membrane induction medium every 1 d. After the culture, a translucent cell membrane appears in the culture well. The edge of the cell membrane is rolled up and can be picked up with tweezers. The cell membrane has certain toughness and is not easy to be damaged, which proves that the membrane is mature.

[0081] The...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of biomedicines and particularly relates to a composition for improving premature ovarian failure, a preparation method therefor and application of the composition. According to the composition for improving the premature ovarian failure, provided by the invention, an in-vitro-constructed human uterine endometrium stem-cell cell membrane and a mesenchymal stem cell exosome are used in a compounded manner, thus, the development of ovarian follicles can be promoted, ovaries can be promoted to secrete an anti-Mullerian hormone, an ovarian follicle generator promoting level can be regulated, the apoptosis of ovarian cells can be inhibited, the adverse reserve function disease of the ovaries can be improved, the effect of improving primary or secondary premature ovarian failure is good, and thus, a new way of think is provided for clinically treating ovarian insufficiency and polycystic ovarian syndrome.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and in particular relates to a composition for improving premature ovarian failure, a preparation method and application thereof. Background technique [0002] Premature ovarian failure refers to the premature decline of ovarian function in women. It is divided into primary premature ovarian failure and secondary premature ovarian failure. It is specifically manifested in some symptoms of ovarian function decline, such as menstrual cycle disorders, abnormal menstrual flow, and even infertility. Existing treatment methods include drugs, surgery, stem cells and stem cell derivatives, tissue engineering methods, etc. Drug treatment mainly consists of taking Chinese and Western medicines. Chinese medicines are taken for a long time, the effect is not obvious, and it is easy to cause liver and kidney toxicity. Western medicines are mainly hormone drugs, but taking hormones for a long time has side...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/48C12N5/074C12N5/0775A61P15/08A61K35/28
CPCA61K35/28A61K35/48A61P15/08C12N5/0662C12N5/0682C12N2500/38
Inventor 董玲娟明磊国王清霞马嘉丽
Owner 陕西中鸿科瑞再生医学研究院有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products